What’s new in OpenText Documentum for Life Sciences Release 16 EP7

Every pharmaceutical company wants to accelerate the drug development process – from discovery to commercial success – to deliver new treatments that improve patient outcomes….

Robin Gellerman  profile picture
Robin Gellerman

November 12, 20194 minute read

Descriptive text explaining the contents of the image.

Every pharmaceutical company wants to accelerate the drug development process – from discovery to commercial success – to deliver new treatments that improve patient outcomes. At OpenText™, the Life Sciences team is committed to delivering better intelligent content services that drive productivity, growth and a lasting competitive advantage.

Collaboration on regulatory submissions

In Life Sciences, submission preparations can often take up to a year or longer. During this time, project team members – including medical writers, regulatory operations, and quality directors – must work together to author, assemble and carefully review the submission. However, collaboration can be time-consuming and it can be difficult to manage changes without insight into the content being authored by others.

With OpenText™ Documentum™ for Life Sciences 16.6.1, collaboration is streamlined and made flexible while maintaining business process controls and adhering to compliance requirements. Documentum for Life Sciences users can now co-author documents in a truly collaborative fashion with real time feedback and review, allowing simultaneous updates by multiple contributors. Users work in a familiar, friendly environment with Microsoft Word and Microsoft SharePoint while connected to the OpenText™ Documentum™ repository.

Users co-author and edit documents in real time.
Users co-author and edit documents in real time.

Documents can also be opened and edited by multiple users at the same time and changes are synchronized automatically. By allowing the team to co-author, each person works on their section of the document while being able to see and comment on what others are writing in real time.

Co-authoring in a GxP environment

With Documentum for Life Sciences 16.6.1, collaboration can be enabled with Office 365 Online and Desktop Editions. Using Office 365 Desktop applications provides multiple benefits, including:

  • Familiar track changes functionality within Microsoft Word
  • Microsoft Word macros support which is required when working with submission documents
  • No compliance concerns when working with Office 365 Desktop Edition

With this highly regulated content, Documentum for Life Sciences ensures that the collaboration process is controlled and recorded in the audit trail.

Change tracking shows collaboration that has occurred between writers, editors and reviewers.
Change tracking shows collaboration that has occurred between writers, editors and reviewers.

Co-author with external users

This new capability also allows collaboration with users who are external to the Documentum for Life Sciences solutions. For example, joint drug development with another pharmaceutical company, contributors from a Contract Research Organizations (CRO) or Contract Manufacturing Organizations (CMO) can co-author documents in a compliant GxP manner.

Real time collaboration for Clinical, Regulatory, and Quality documents

Co-authoring is available for all the solutions in the Documentum for Life Sciences family including:

Flexible Document Sharing

Documentum for Life Sciences 16.6.1 release offers some additional features that allow users to work with content more efficiently.

Many Documentum for Life Sciences clients extensively use Virtual Documents to organize documents in logical structures to facilitate multiple use cases, such as clinical or nonclinical study reports and submissions structures. Part of this process requires sharing content with external parties, such as affiliates and legal departments. Documentum for Life Sciences 16.6.1 allows the user to export Virtual Documents which preserves the document structure and provides options to work with native documents or PDF renditions. This capability is extremely useful when sharing content outside of a repository is required.

When working with translation services, another common requirement is to allow authorized users to view or export native content for finalized documents. Documentum for Life Sciences 16.6.1 provides both options which streamlines communications with external parties.     

Learn more about OpenText Documentum for Life Sciences by visiting our website.

Accelerate your upgrade and reduce risk by working with OpenText Professional Services. Customers who have Professional Services-led upgrades report 75% fewer queries to Customer Support. Let our experts work with you to assess the current environment and prepare recommendations for a successful upgrade, whether on-premises, in the OpenText Cloud, in other company’s clouds or in a hybrid environment.

Share this post

Share this post to x. Share to linkedin. Mail to
Robin Gellerman avatar image

Robin Gellerman

Robin Gellerman is the Product Marketing Manager for Life Sciences Enterprise Content Management solutions at OpenText. With over 20 years in the enterprise content management industry, Robin has held a variety of product and industry marketing positions supporting document management, capture and customer communications technologies at OpenText, the Enterprise Content Division of EMC, Captiva and Document Sciences. Most recently, Robin was the Industry Strategist for retail, and has previously worked with energy & engineering and healthcare solutions.

See all posts

More from the author

Top information management trends for life sciences in 2024

Top information management trends for life sciences in 2024

The life sciences industry has seen monumental change over the past few years. From the Covid-19 pandemic to a spike in investment, coupled with rising…

November 30, 2023 5 minute read

Assembling the pieces: Archiving and retention in Life Sciences

Assembling the pieces: Archiving and retention in Life Sciences

In the world of pharmaceuticals, something interesting keeps happening—companies acquire, merge, or divest from other companies. It’s like a puzzle they’re trying to solve getting…

September 21, 2023 4 minute read

What’s new in OpenText Life Sciences solutions

What’s new in OpenText Life Sciences solutions

Life Sciences organizations are finding new ways to work within distributed and hybrid work processes adopted during the pandemic that remains in place today. Mastering…

February 16, 2023 12 minute read

Stay in the loop!

Get our most popular content delivered monthly to your inbox.